Cargando…
Mitochondrial metabolic reprogramming by SIRT3 regulation ameliorates drug resistance in renal cell carcinoma
Clear cell renal cell carcinoma (ccRCC) alters metabolic signals frequently, leading to mitochondrial dysfunction, such as increase of glycolysis and accumulation of lipid. Sirtuin3 (SIRT3) is a key factor for the regulation of both mitochondrial integrity and function. SIRT3 is downregulated and co...
Autores principales: | Gu, Young-Ran, Kim, Jinu, Na, Joon Chae, Han, Woong Kyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9173632/ https://www.ncbi.nlm.nih.gov/pubmed/35671305 http://dx.doi.org/10.1371/journal.pone.0269432 |
Ejemplares similares
-
Establishment of patient-derived three-dimensional organoid culture in renal cell carcinoma
por: Na, Joon Chae, et al.
Publicado: (2020) -
Prolyl hydroxylase-3 is a novel renal cell carcinoma biomarker
por: Kim, Kwang Hyun, et al.
Publicado: (2019) -
Robotic ureter reconstruction using the native ureter to treat long-segment ureteral stricture of the transplant kidney utilizing Indocyanine green: The first Korean experience
por: Kim, Jinu, et al.
Publicado: (2023) -
Metabolic reprogramming of clear cell renal cell carcinoma
por: Zhu, Haiyan, et al.
Publicado: (2023) -
Clinical validation of serum endocan (ESM-1) as a potential biomarker in patients with renal cell carcinoma
por: Kim, Kwang Hyun, et al.
Publicado: (2017)